Balyasny Asset Management L.P. Sells 2,558,478 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Balyasny Asset Management L.P. lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 98.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 42,244 shares of the real estate investment trust's stock after selling 2,558,478 shares during the quarter. Balyasny Asset Management L.P.'s holdings in Healthpeak Properties were worth $856,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Principal Financial Group Inc. increased its position in shares of Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after buying an additional 17,314,572 shares during the period. Norges Bank bought a new position in Healthpeak Properties in the 4th quarter worth about $166,804,000. Long Pond Capital LP bought a new position in Healthpeak Properties in the 4th quarter worth about $86,885,000. JPMorgan Chase & Co. boosted its stake in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Up 0.5%

Shares of NYSE DOC traded up $0.08 during midday trading on Monday, reaching $17.71. 3,605,262 shares of the company's stock traded hands, compared to its average volume of 5,379,209. The company has a market cap of $12.30 billion, a price-to-earnings ratio of 50.60, a P/E/G ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a one year low of $16.90 and a one year high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock's 50 day simple moving average is $18.78 and its 200-day simple moving average is $20.04.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The business had revenue of $702.89 million during the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the company posted $0.45 earnings per share. On average, analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be given a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's payout ratio is presently 305.00%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Wedbush cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Argus restated a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. StockNews.com downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Evercore ISI lowered their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Finally, Scotiabank lowered their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $23.45.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,700 shares of the stock in a transaction dated Friday, May 9th. The shares were acquired at an average cost of $17.36 per share, for a total transaction of $98,952.00. Following the completion of the transaction, the director now directly owns 138,513 shares of the company's stock, valued at $2,404,585.68. This trade represents a 4.29% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John T. Thomas bought 4,200 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the transaction, the director now owns 813,566 shares of the company's stock, valued at $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 23,987 shares of company stock valued at $422,141 over the last quarter. 0.23% of the stock is owned by company insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.